|Assisted Reproductive Technology:
Infertility is often defined as not being able to get pregnant after
trying for one year. Of the approximately 62 million women of reproductive
age in 2002, about 1.2 million, or 2%, had an infertility-related medical
appointment within the previous year, and 8% had an infertility-related
medical visit at some point in the past. (Infertility services include medical
tests to diagnose infertility, medical advice and treatments to help a woman
become pregnant, and services other than routine prenatal care to prevent
miscarriage.) Additionally, 7% of married couples in which the woman was
of reproductive age (2.1 million couples) reported that they had not used
contraception for 12 months and the woman had not become pregnant (2002
National Survey of Family Growth).
Thus, for many people who want to start a family, the dream of having
a child is not easily realized. Assisted Reproductive Technology (ART)
has been used in the United States since 1981 to help women become
pregnant, most commonly through the transfer of fertilized human eggs
into a woman’s uterus (in vitro fertilization). However, deciding
whether to undergo this expensive and time-consuming treatment can be
What is Assisted Reproductive Technology (ART)?
Although various definitions have been used for ART, the definition used
by CDC is based on the
Clinic Success Rate and Certification Act that requires CDC to publish
the annual ART success rates report. According
to this definition, ART includes all fertility treatments in which both
eggs and sperm are handled. In general, ART procedures involve surgically
removing eggs from a woman’s ovaries, combining them with sperm in the laboratory,
and returning them to the woman’s body or donating them to another woman.
They do NOT include treatments in which only sperm are handled (i.e., intrauterine—or
artificial—insemination) or procedures in which a woman takes medicine only
to stimulate egg production without the intention of having eggs retrieved.
The goal of this report is to help potential ART users make informed
decisions about ART by providing some of the information needed to answer
the following questions:
What are my chances of having a child by using ART?
Where can I go to get this treatment?
2006 Assisted Reproductive
Technology Success Rates
National Summary and Fertility Clinic Reports
The data for this national report comes from the
483 fertility clinics in operation in 2006 that provided and verified data on
the outcomes of all ART cycles started at their clinics. The
cycles performed at these reporting clinics in 2006 resulted in
births (deliveries of one or more living infants) and
54,656 infants. Data
provided by U.S. fertility clinics that use ART to treat infertility is a
rich source of information about the factors that contribute to a successful
ART treatment—the delivery of a live-born infant.
Previous ART Reports
- 2005 | 2004 | 2003 |
2000–1995 (PDF format only)
Excel Spreadsheets of the ART clinic data
Assisted Reproductive Technology Surveillance—United States, 2005
These surveillance summaries include detailed statistics from the Assisted Reproductive Technology (ART) Surveillance System by state/territory of residence. The report expands information on geography and determinants of ART success and the risks associated with ART procedures (e.g., multiple births, low birthweight, and preterm delivery) beyond what appears in the
2005 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Report. Source: MMWR 2008;57 (No. SS-5) 1–23.
Errata: Vol. 57, No. SS-5 Source: MMWR 2008 /
Previous ART Surveillance Summary
Birth Defects Prevention Study Shows Assisted Reproductive Technology is
Associated with an Increased Risk of Certain Birth Defects
Infants conceived with Assisted Reproductive Technology (ART) are two to
four times more likely to have certain types of birth defects than
children conceived naturally, according to a study by the CDC released
in the journal Human Reproduction.
infant mortality among very low birthweight infants — Delaware, 1994–2000,
of Assisted Reproductive Technology—United States, 1996 and 1998
Since 1983, when the first infant was conceived from in vitro fertilization
(IVF) in the United States, the use of IVF and related procedures (assisted
reproductive technology) has increased substantially. Source: MMWR 2002;51(05):97–101.
of Assisted Reproductive Technology and Ovulation-Inducing Drugs to
Triplet and Higher-Order Multiple Births— United States, 1980–1997
Pregnancies associated with assisted reproductive technology (ART) and
drugs that induce ovulation are more likely to result in multiple births
than spontaneously conceived pregnancies in the United States. Source:
Division of Reproductive
Health's ART Surveillance System
In the U.S. and worldwide, assisted reproductive technologies (ARTs) are
increasingly used to overcome all types of infertility disorders.
FAQ's (National Women's Health Information Center)
Do I Know If I Have an Infertility Problem?* (Resolve: The National
(March of Dimes)*
American Fertility Association*
The American Fertility Association (AFA) is a national consumer
organization that offers support for men and women dealing with
infertility. Their purpose is to educate the public about reproductive
disease, and support families during struggles with infertility and
Fertile Hope is a national nonprofit organization dedicated to providing
reproductive information, support and hope to cancer patients whose
medical treatments present the risk of infertility.
American Society for Reproductive Medicine*
The American Society for Reproductive Medicine (ASRM) is a
multidisciplinary organization for the advancement of information,
education, advocacy and standards in the field of reproductive medicine.
RESOLVE: The National Infertility
RESOLVE is a national consumer organization that offers support for men
and women dealing with infertility. Their purpose is to provide timely,
compassionate support and information to people who are experiencing
infertility and to increase awareness of infertility issues through
public education and advocacy.
Society for Assisted Reproductive
The Society for Assisted Reproductive Technology (SART) promotes and
advances the standards for the practice of assisted reproductive
technology to the benefit of patients, members and society at large.
The purpose of the Tissue Action Plan is to develop the policies, regulations
and guidance documents for regulation of cellular and tissue-based products
Human Cell, Tissues
and Cellular and Tissue-Based Products (FDA)
Listing of ART clinics registered with FDA.
Implementation of the Fertility Clinic Success Rate and Certification
Act of 1992: A Model Program for the Certification of Embryo
This notice sets forth the model certification program requirements, including
definitions, administrative requirements, and embryo laboratory standards.
The model program incorporates comments received by CDC on the proposed
model certification program that was published in the Federal
Technology: Embryo Laboratory
This site links to the (1) January 1999 report entitled Survey of Assisted
Reproductive Technology: Embryo Laboratory Procedures and Practices (119
pages); and (2) Proposed Model Certification Program for Embryo Laboratories
as required by the Fertility Clinic Success Rate and Certification Act of
Search PubMed for articles on Assisted Reproductive Technology
This search is being conducted on PubMed an NLM/NIH service.
|Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organization Web pages found at these links.
last reviewed: 1/7/09
To learn more about PDF
files and to download PDF files, you need Adobe Acrobat Reader software,
available free of charge from Adobe. The HTML version alters the
format of the original printed document. Using the PDF version will
preserve the document's formatting and graphics.
Page last modified: 1/7/09
Content source: Division
of Reproductive Health, National
Center for Chronic Disease Prevention and Health Promotion